Navigation Links
Study finds first-ever genetic animal model of autism
Date:12/8/2007

Boca Raton, FL, December 8, 2007 By introducing a gene mutation in mice, investigators have created what they believe to be the first accurate model of autism not associated with a broader neuropsychiatric syndrome, according to research presented at the American College of Neuropsychopharmacology annual meeting. This animal model could help researchers better understand abnormal brain function in autistic humans, which could help them identify and improve treatment strategies. Broader neuropsychiatric conditions include Fragile X, the most common cause of inherited mental impairment, and Rett Syndrome, a childhood neurodevelopmental disorder characterized by normal early development followed by slowed brain and head growth, seizures, and mental retardation.

Autism is a neuropsychiatric disorder characterized by repetitive behaviors and by impairment in social interactions and communication skills. These symptoms can coexist with either enhanced or decreased cognitive abilities and skills.

Prior to this study we knew next to nothing about the mechanisms of autism in the brain, says study researcher Craig M. Powell, M.D., Ph.D., assistant professor of neurology and psychiatry at the University of Texas Southwestern Medical Center at Dallas. With this research, we can study changes in the brain that lead to autistic behaviors and symptoms, which may help us understand more about progression and treatment of the disorder.

The research team, led by Thomas Sdhof, M.D., professor and chairman of neuroscience at UT Southwestern, replaced the normal mouse neurologin-3 gene with a mutated neuroligin-3 gene associated with autism in humans. By doing so, the team was able to create a gene in the mice that is similar to the human autism disease gene. While the result amounted to a very small change in their genetic makeup, it perfectly mimicked the same small change occurring in some patients with human autism.

Dr. Powell studied t
'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
American College of Neuropsychopharmacology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Study begins to reveal clues to the cause and progression of sepsis
4. Clones on task serve greater good, evolutionary study shows
5. New study warns limited carbon market puts 20 percent of tropical forest at risk
6. New study examines how rearing environment can alter navigation
7. Study links cat disease to flame retardants in furniture and to pet food
8. New continent and species discovered in Atlantic study
9. Study shows link between alcohol consumption and hiv disease progression
10. Feeling hot, hot, hot: New study suggests ways to control fever-induced seizures
11. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...ewswire-FirstCall/ -- Quest Diagnostics Incorporat...diagnostic testing, information and services, anno...0, 2009, income from continuing operations rose to...60 million, or $0.81 per diluted share, for the th...s were reduced by a $0.03 per share charge associa...
(Date:11/4/2009)...PRNewswire/ -- GenVault Corporation, the leader in...mic discovery, medicine and identification, today ...sident and CEO, will be presenting at the BIOCOM I...d 27th in La Jolla, CA. ,, During the presentat...mpany together with recent customer, technical and...
(Date:11/4/2009)...RNewswire/ -- GenVault Corporation (Carlsbad, CA) ...as joined its Board of Directors. Dr. Brody, the ...ute, is an acclaimed physician-scientist and unive..., Dr. Brody served as president of The Johns Hopki...demy of Engineering and the Institute of Medicine,...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 1SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 3REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 4REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 5Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 1Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 2
...y (ASH TM ) and American Board of Internal Medicin...a new wave of performance evaluation tools for blo...uirements to maintain ABIM certification, ASH and ...rovement Module (PIM), a web-based tool physicians...ment requirement for recertification. Participants...
...is the deadliest form of the disease, with fewer t...ear prognosis for survival. To find out what drive...d to rapidly screen for drugs that might stop IBC... Diego (UCSD), have come up with an unlikely yet ...ble for xenografts. , More properly, it’s a trans...
...s are heading a worldwide research project which c...diarrhoea in children in developing countries. , T... being piloted in four hospitals in India, will of...ms of the disease quickly, cheaply and with little...ications for improving children,s health could be ...
Other Biology News:New tool helps blood specialists improve patient care 2A fisheye view of the deadliest breast cancer 2Hope for major advance in fighting world killer disease 2Hope for major advance in fighting world killer disease 3
(Date:11/5/2009)...YNBROOK, N.Y., Nov. 5 Bi...biopharmaceutical company developing first-in-clas...financial results for the third quarter ended Sept...at, in September of this year, the FDA,s Arthritis...vote of 12-0, the approval of XIAFLEX(TM) for the ...
(Date:11/5/2009)...AN DIEGO, CA, November 5, 2009 /PRNewswire-FirstCa...ocused on using proprietary taste receptor-based t...or the food, beverage, and ingredient supply indus...ted financial results for the third quarter ended ...r the third quarter of 2009, compared to $4.0 mill...
(Date:11/5/2009)... PLYMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-...JGP ) ("BMP Sunstone" or the "Company") today anno...ter 2009 financial results on,Monday, November 9, ...any will hold a conference call at 5:00 pm ET on N...lts. Listeners may access the call by,dialing 1-8...
(Date:11/5/2009)... Brooke Sanders brings a new loo...CA (PRWEB) November 5, 2009 -- Professional Reprog...rographics company is pleased to present Brooke Sa...their graphics/PR specialist. The addition of Broo...ent growth within Professional Reprographics., , ,...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...elixis,Inc. (Nasdaq: EXEL ) announced earlier tod...ommitment from Deerfield Management. The arrangeme...ive conference call at 5:00 a.m.,PT/8:00 a.m. ET t...the,discussion, visit the Event Calendar page unde...ay of the conference call will be available until ...
...ne Control, Trait Stacking in ...MOND, Calif., June 5 Dow,AgroSciences LLC and San...today the successful completion of research milest...l License Agreement. These milestones represent,th...DNA-binding protein,(ZFP) technology to the genera...
...C Santa Barbara,s Solid-State Lighting and Energy ...nce of Asturias Award for Technical and Scientific... is presented with a medal and a Joan Miro sculptu...ecipients in each category also share a 50,000 (US...esearch prize is given annually to "the individual...
Other Biology Technology:Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 2Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 3Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 4Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 5
Mouse Anti-Human TNPO2 Polyclonal Antibody, Unconjugated from Novus Biologicals
... ChIP Grade HDAC4 is a member of the class II mam...4 amino acid residues. Its C-terminal sequence is ...HDA1. HDAC4, unlike other deacetylases, shuttles b...lving active nuclear export. Association of HDAC4 ...
FluoroGuard Antifade Reagent from Bio-Rad
Mouse Anti-Human PDK2 Monoclonal Antibody, Unconjugated, Clone 2G1 from Novus Biologicals
Biology Products: